Ana Maria Corregidor
Dr. Corregidor joins us after completing her transplant/hepatology fellowship at the MAYO Clinic in Jacksonville. In addition to her special training in liver diseases, Ana completed a fellowship in gastroenterology at the University of Florida. She has a special interest in pre and post liver transplant evaluation and management. Dr. Corregidor is the medical director of Borland Groover's Liver Center, and is active in several clinical trials investigating new drugs in the treatment of Hepatitis C and B and other liver diseases. In addition, Dr. Corregidor performs colonoscopy and upper endoscopy.
2001 – 2002
Fellowship, Hepatology and Liver Transplantation
Mayo Clinic Jacksonville, Jacksonville, FL
2001 – 1998
University of Florida, Shands Jacksonville, FL
1998 – 1995
Internship and Residency: Internal Medicine
St. Lukes Hospital, University of Columbia, MO St. Louis, MO
- Lawitz E, Sulkowski MS, Ghalib R, Rodriguez-Torres M, Younossi ZM, Corregidor A, et al. Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. Lancet 2014;384:1756–1765.
- Simeprevir plus sofosbuvir, with or without ribavirin, to treat chronic infection with hepatitis C virus genotype 1 in non-responders to pegylated interferon and ribavirin and treatment-naive patients: the COSMOS randomised study. Lawitz E1, Sulkowski MS2, Ghalib R3, Rodriguez-Torres M4, Younossi ZM5, Corregidor A6, DeJesus E7, Pearlman B8, Rabinovitz M9, Gitlin N10, Lim JK11, Pockros PJ12, Scott JD13, Fevery B14, Lambrecht T15, Ouwerkerk-Mahadevan S14, Callewaert K14, Symonds WT16, Picchio G17, Lindsay KL17, Beumont M14, Jacobson IM18
- 45 year old woman with lower abdominal pain and constipation
- Oral presentation at ACG National Fellows Forum, San Diego, California, 1999